CME

Project ECHO® Learning Series

Join ACCC, Physicians’ Education Resource (PER), and Pharmacy Times Continuing Education (PTCE) for a series of expert-led telementoring sessions focused on the optimal use of bispecific antibodies as cancer immunotherapies.
Powered by OncoLens.

LEARN MORE

Hitting the Benchmarks in mCRC: A Precision Medicine Quality Initiative for the Care Team

0.75 CME/MOC/CC/NCPD/CPE/AAPA/IPCE

Topics — PeerView

Melanoma Oncolytic Immunotherapy: An Evolving Therapeutic Landscape

Maximum of 1.25 AMA PRA Category 1 Credit(s)™.

Topics — advanced melanoma, melanoma immunotherapy, oncolytic immunotherapy, PD-1 resistant melanoma, Vindico

Project ECHO® Learning Series: Evolving Role of Bispecific Antibodies as Cancer Therapy

These activities will be CME/CPE/CNE-certified.

Topics — ACCC, PER, Project ECHO, PTCE

Project ECHO®: Pulmonary Toxicities with Immune Checkpoint Inhibitors

Content Derived from a CME Certified Webinar in May 2023

Topics — ACCC, Boston University, immunotherapy, irAE, Project ECHO, pulmonology

Project ECHO®: Dermatologic Toxicities with Immune Checkpoint Inhibitors

Content Derived from a CME Certified Webinar in April 2023

Topics — ACCC, Boston University, dermatology, immunotherapy, irAE, Project ECHO

Project ECHO®: Hepatobiliary Toxicities with Immune Checkpoint Inhibitors

Content Derived from a CME Certified Webinar in March 2023

Topics — ACCC, Boston University, hepatology, immunotherapy, irAE, Project ECHO

Project ECHO®: Neurological Toxicities with Immune Checkpoint Inhibitors

Content Derived from a CME Certified Webinar in February 2023

Topics — ACCC, Boston University, immunotherapy, irAE, neurology, Project ECHO

Project ECHO®: Rheumatologic Toxicities with Immune Checkpoint Inhibitors

Content Derived from a CME Certified Webinar in January 2023

Topics — ACCC, Boston University, immunotherapy, irAE, Project ECHO, rheumatology

Project ECHO®: Endocrine Toxicities with Immune Checkpoint Inhibitors

Content Derived from a CME Certified Webinar in November 2022

Topics — ACCC, Boston University, endocrinology, immunotherapy, irAE, Project ECHO

Project ECHO®: Gastroenterology Toxicities with Immune Checkpoint Inhibitors

Content Derived from a CME Certified Webinar in October 2022

Topics — ACCC, Boston University, gastroenterology, immunotherapy, irAE, Project ECHO

Project ECHO®: Cardiovascular Toxicities with Immune Checkpoint Inhibitors

Content Derived from a CME Certified Webinar in September 2022

Topics — ACCC, Boston University, cardiovascular, immunotherapy, irAE, Project ECHO

Project ECHO® Learning Series: Telementoring to Manage Immune-Related Adverse Events in Patients Receiving Cancer Immunotherapies

These activities will be CME/CPE/CNE-certified.

Topics — ACCC, Boston University, immunotherapy, irAE, Project ECHO

Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer

Physician: .75 AMA PRA Category 1 Credit(s)™

Topics — NSCLC

Molecular Testing in the Community Oncology Setting

Content Derived from a CME Certified Webinar in June 2021

Topics — breast cancer, gastric cancer, lung cancer, NSCLC

Project ECHO® Learning Series

2,000,000+

85-90%

235,000+

Project ECHO® Learning Series

2,000,000+

118,000+

19,000+

CME

Project ECHO® Learning Series

Hitting the Benchmarks in mCRC: A Precision Medicine Quality Initiative for the Care Team

Melanoma Oncolytic Immunotherapy: An Evolving Therapeutic Landscape

Project ECHO® Learning Series: Evolving Role of Bispecific Antibodies as Cancer Therapy

Project ECHO®: Pulmonary Toxicities with Immune Checkpoint Inhibitors

Project ECHO®: Dermatologic Toxicities with Immune Checkpoint Inhibitors

Project ECHO®: Hepatobiliary Toxicities with Immune Checkpoint Inhibitors

Project ECHO®: Neurological Toxicities with Immune Checkpoint Inhibitors

Project ECHO®: Rheumatologic Toxicities with Immune Checkpoint Inhibitors

Project ECHO®: Endocrine Toxicities with Immune Checkpoint Inhibitors

Project ECHO®: Gastroenterology Toxicities with Immune Checkpoint Inhibitors

Project ECHO®: Cardiovascular Toxicities with Immune Checkpoint Inhibitors

Project ECHO® Learning Series: Telementoring to Manage Immune-Related Adverse Events in Patients Receiving Cancer Immunotherapies

Optimizing Frontline Immunotherapy in Advanced Non-Small Cell Lung Cancer

Molecular Testing in the Community Oncology Setting